Abstract
RGS1 (regulator of G-protein signaling 1) has been associated with multiple autoimmune disorders including type I diabetes. RGS1 desensitizes the chemokine receptors CCR7 and CXCR4 that are critical to the localization of T and B cells in lymphoid organs. To explore how RGS1 variation contributes to autoimmunity, we generated Rgs1 knockdown (KD) mice in the nonobese diabetic (NOD) model for type I diabetes. We found that Rgs1 KD increased the size of germinal centers, but decreased the frequency of T follicular helper (TFH) cells. We show that loss of Rgs1 in T cells had both a T cell-intrinsic effect on migration and TFH cell frequency, and an indirect effect on B-cell migration and germinal center formation. Notably, several recent publications described an increase in circulating TFH cells in patients with type I diabetes, suggesting this cell population is involved in pathogenesis. Though Rgs1 KD was insufficient to alter diabetes frequency in the NOD model, our findings raise the possibility that RGS1 plays a role in autoimmunity owing to its function in TFH cells. This mechanistic link, although speculative at this time, would lend support to the notion that TFH cells are key participants in autoimmunity and could explain the association of RGS1 with several immune-mediated diseases.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 6 digital issues and online access to articles
$119.00 per year
only $19.83 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Moratz C, Harrison K, Kehrl JH . Regulation of chemokine-induced lymphocyte migration by RGS proteins. Methods Enzymol 2004; 389: 15–32.
Smyth DJ, Plagnol V, Walker NM, Cooper JD, Downes K, Yang JH et al. Shared and distinct genetic variants in type 1 diabetes and celiac disease. N Engl J Med 2008; 359: 2767–2777.
International Multiple Sclerosis Genetics Wellcome Trust Case Control Consortium 2 Sawcer S, Hellenthal G Pirinen M Spencer CC et al. Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis. Nature 2011; 476: 214–219.
Barrett JC, Clayton DG, Concannon P, Akolkar B, Cooper JD, Erlich HA et al. Genome-wide association study and meta-analysis find that over 40 loci affect risk of type 1 diabetes. Nat Genet 2009; 41: 703–707.
Bradfield JP, Qu H-Q, Wang K, Zhang H, Sleiman PM, Kim CE et al. A genome-wide meta-analysis of six type 1 diabetes cohorts identifies multiple associated loci. PLoS Genet 2011; 7: e1002293.
Ebert LM, Schaerli P, Moser B . Chemokine-mediated control of T cell traffic in lymphoid and peripheral tissues. Mol Immunol 2005; 42: 799–809.
Oldham WM, Hamm HE . Heterotrimeric G protein activation by G-protein-coupled receptors. Nat Rev Mol Cell Biol 2008; 9: 60–71.
Reif K, Cyster JG . RGS molecule expression in murine B lymphocytes and ability to down-regulate chemotaxis to lymphoid chemokines. J Immunol 2000; 164: 4720–4729.
Moratz C, Hayman JR, Gu H, Kehrl JH . Abnormal B-cell responses to chemokines, disturbed plasma cell localization, and distorted immune tissue architecture in Rgs1 − / − mice. Mol Cell Biol 2004; 24: 5767–5775.
Han S-B, Moratz C, Huang NN, Kelsall B, Cho H, Shi CS et al. Rgs1 and Gnai2 regulate the entrance of B lymphocytes into lymph nodes and B cell motility within lymph node follicles. Immunity 2005; 22: 343–354.
Hwang IY, Park C, Harrison KA, Huang NN, Kehrl JH . Variations in Gnai2 and Rgs1 expression affect chemokine receptor signaling and the organization of secondary lymphoid organs. Genes Immun 2010; 11: 384–396.
Gibbons DL, Abeler-Dörner L, Raine T, Hwang I-Y, Jandke A, Wencker M et al. Cutting edge: regulator of G protein signaling-1 selectively regulates gut T cell trafficking and colitic potential. J Immunol 2011; 187: 2067–2071.
Victora GD, Nussenzweig MC . Germinal centers. Annu Rev Immunol 2012; 30: 429–457.
Nurieva RI, Chung Y, Martinez GJ, Yang XO, Tanaka S, Matskevitch TD et al. Bcl6 mediates the development of T follicular helper cells. Science 2009; 325: 1001–1005.
Haynes NM, Allen CDC, Lesley R, Ansel KM, Killeen N, Cyster JG . Role of CXCR5 and CCR7 in follicular Th cell positioning and appearance of a programmed cell death gene-1high germinal center-associated subpopulation. J Immunol 2007; 179: 5099–5108.
Linterman MA, Pierson W, Lee SK, Kallies A, Kawamoto S, Rayner TF et al. Foxp3(+) follicular regulatory T cells control the germinal center response. Nat Med 2011; 17: 975–982.
Xu X, Shi Y, Cai Y, Zhang Q, Yang F, Chen H et al. Inhibition of increased circulating Tfh cell by anti-CD20 monoclonal antibody in patients with type 1 diabetes. PLoS One 2013; 8: e79858.
Ferreira RC, Simons HZ, Thompson WS, Cutler AJ, Dopico XC, Smyth DJ et al. IL-21 production by CD4+ effector T cells and frequency of circulating follicular helper T cells are increased in type 1 diabetes patients. Diabetologia 2015; 58: 781–790.
Kenefeck R, Wang CJ, Kapadi T, Wardzinski L, Attridge K, Clough LE et al. Follicular helper T cell signature in type 1 diabetes. J Clin Invest 2015; 125: 292–303.
Delovitch TL, Singh B . The nonobese diabetic mouse as a model of autoimmune diabetes: immune dysregulation gets the NOD. Immunity 1997; 7: 727–738.
Zheng P, Kissler S . PTPN22 silencing in the NOD model indicates the type 1 diabetes-associated allele is not a loss-of-function variant. Diabetes 2013; 62: 896–904.
Herold MJ, van den Brandt J, Seibler J, Reichardt HM . Inducible and reversible gene silencing by stable integration of an shRNA-encoding lentivirus in transgenic rats. Proc Natl Acad Sci USA 2008; 105: 18507–18512.
Brode S, Raine T, Zaccone P, Cooke A . Cyclophosphamide-induced Type-1 diabetes in the NOD mouse is associated with a reduction of CD4+ CD25+ Foxp3+ regulatory T cells. J Immunol 2006; 177: 6603–6612.
Dirice E, Kahraman S, Jiang W, El Ouaamari A, De Jesus DF, Teo AKK et al. Soluble factors secreted by T cells promote β-cell proliferation. Diabetes 2014; 63: 188–202.
Allen CDC, Ansel KM, Low C, Lesley R, Tamamura H, Fujii N et al. Germinal center dark and light zone organization is mediated by CXCR4 and CXCR5. Nat Immunol 2004; 5: 943–952.
Crotty S . T follicular helper cell differentiation, function and roles in disease. Immunity 2014; 41: 529–542.
Romme Christensen J, Bornsen L, Ratzer R, Piehl F, Khademi M, Olsson T et al. Systemic inflammation in progressive multiple sclerosis involves follicular T-helper, Th17- and activated B-cells and correlates with progression. PLoS One 2013; 8: e57820.
Fan X, Jin T, Zhao S, Liu C, Han J, Jiang X et al. Circulating CCR7+ICOS+ memory T follicular helper cells in patients with multiple sclerosis. PLoS One 2015; 10: e0134523.
Lindén M, Khademi M, Lima Bomfim I, Piehl F, Jagodic M, Kockum I et al. Multiple sclerosis risk genotypes correlate with an elevated cerebrospinal fluid level of the suggested prognostic marker CXCL13. Mult Scler 2013; 19: 863–870.
Kissler S . From genome-wide association studies to etiology: probing autoimmunity genes by RNAi. Trends Mol Med 2011; 17: 634–640.
Acknowledgements
We acknowledge support from the Joslin DRC Flow Cytometry Core facility. This work was supported in part by a Career Development Award (2-2010-383) and an Innovative Award (1-INO-2014-169-A-V) from JDRF to SK, and by a DRC award (NIH Award Number P30DK036836) to the Joslin Diabetes Center.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Additional information
Supplementary Information accompanies this paper on Genes and Immunity website
Supplementary information
Rights and permissions
About this article
Cite this article
Caballero-Franco, C., Kissler, S. The autoimmunity-associated gene RGS1 affects the frequency of T follicular helper cells. Genes Immun 17, 228–238 (2016). https://doi.org/10.1038/gene.2016.16
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/gene.2016.16
This article is cited by
-
The NF-κB Pathway: a Focus on Inflammatory Responses in Spinal Cord Injury
Molecular Neurobiology (2023)